TrialThe Korean journal of internal medicine2023

Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study.

Jeong Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.